Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district, Telangana, India

Jothula, Kishore Yadav; Naidu, Navya K.; Malhotra, Varun; Prasad, V G; Kabra, P R; Nagaraj, K

doi:10.18203/2394-6040.ijcmph20162241

Cited by 6 publications

(10 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Consistent results were reported by Jothula KY etal, Prasad V G et al found 1.14%, 1.81% of adverse effects after consuming DEC. (12), (19) This study showed 86.67% households were aware regarding MDA activity from various sources like ASHA, anganwadi workers, health workers, mike announcement etc. which is higher as compare to study done by Ranganath TS et al where only 55 % population were aware about MDA activity.…”

Section: Discussionmentioning

confidence: 92%

“…[18] Different studies gave different explanations for reason for non-compliance [9][10][11][12][13][14][15][16][17] In this study, only 6 persons (1.38%) had mild adverse reactions like nausea, vomiting, mild fever etc after consuming DEC. Consistent results were reported by Jothula KY etal, Prasad V G et al found 1.14%, 1.81% of adverse effects after consuming DEC. (12), (19) This study showed 86.67% households were aware regarding MDA activity from various sources like ASHA, anganwadi workers, health workers, mike announcement etc.…”

Section: Discussionmentioning

confidence: 99%

“…Several other studies across India revealed varied compliance of MDA ranging from 38.8% to 81.15%. [10][11][12][13][14][15] MDA should be implemented in more than 85% of the population in endemic areas and must be sustained for at least five years so that it will interrupt the transmission of filariasis. (3) However in this survey, the effective coverage rate was 77.78% which was lower than the standard target level.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Jadhao¹

2017

JMSCR

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Jadhao¹

2017

JMSCR

View full text Add to dashboard Cite

“…In various study conducted in different place in India by Anil, Lata et al, Naveenkumar, Kishore, Amarnath, Muralidhar et al and Nirgude et al also found low compliance rate than recommended level. [8][9][10][14][15][16][17] There is gender wise and age group wise differences in compliance rate in present study. A detailed inquiry into the matter might help us determine the cultural and social factors related age and gender which could have played a role in the compliance rate.…”

Section: Compliance Rate Of Mdamentioning

confidence: 95%

“…The main reason for non-compliance to MDA in the present study was not suffering from the concerned disease at the time of drug distribution 135 (55.78%), followed by fear of side effects 54 (22.31%) and which is in sharp contrast to studies by Biradar, Anil, Lata, Kishore and Karmakar where the main reason for noncompliance was fear of side effects of drugs. 3,8,9,14,18 It is very important that people are made aware that although they are not suffering from the concerned disease but are at risk for acquiring concerned disease.…”

Section: Factors Responsible For Noncompliance To Mdamentioning

confidence: 99%

Evaluation of coverage, compliance of mass drug administration and assessment of awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh: a cross sectional study

Panika¹,

Sahu²

2019

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: Lymphatic filariasis is the second leading cause of disability worldwide accounting for more than 5 million disability adjusted life years annually. It has been a major public health problem in India which leads to irreversible chronic manifestations which are responsible for considerable economic loss and severe physical disability to the affected individuals. Mass drug administration (MDA) means administration of diethylcarbamazine and albendazole tablets to all people (excluding children <2 years, pregnant women, seriously ill persons) in endemic areas once in a year. The objective of the study was to assess coverage, compliance of MDA and awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh.Methods: Cross-sectional study was conducted and total 120 households were surveyed in four randomly selected clusters of Tikamgarh district of Madhya Pradesh.Results: Out of total 743 persons 678 (91.25%) persons were eligible for MDA. Coverage rate was 86.57% and compliance rate was 74.27%. The main reason for non-compliance was not having the concerned disease (55.78%) followed by fear of side effect (22.31%). Only 40.83% among the surveyed families were aware about MDA and only 45.83% respondents had heard about lymphatic filariasis.Conclusions: There is coverage and compliance gap and awareness about the lymphatic filariasis and MDA program is limited. Drug compliance need to be improved and awareness need to be raised. MDA program should not be confined to tablet distribution only and due importance should be given to compliance rate.

show abstract

Evaluation of coverage of mass drug administration programme conducted in Nalgonda district of Telangana state

Ganapa¹,

Jothula²,

Guthi³

et al. 2018

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: Lymphatic filariasis has been a major public health problem in India. Government of India during 2004 initiated Mass Drug Administration (MDA) with annual single dose of DEC tablets to all the population living at the risk of filariasis. Nalgonda is endemic district where MDA programme is undertaken every year to eliminate lymphatic filariasis. The present study was undertaken to evaluate the coverage and compliance rates of the MDA programme conducted during January 2018.Methods: The guidelines of National Vector Borne Disease Control Programme (NVBDCP) were used to select a total of 129 households from four clusters (three rural and one urban). Each household was visited by a team and data was recorded on pre-structured questionnaire available in operational guidelines manual of NVBDCP. Data analyzed by SPSS version 22.Results: Total of 129 households were included in the study, Among the 523 study population, only 494 were eligible population to receive MDA. Current study shows that coverage rate was 79.84% and compliance rate was 84.6%. Fear of side effects was most common reason for noncompliance.Conclusions: Efforts should be made to improve coverage rates by involving more human resources, supervision and incentives. Though compliance rates were higher than required there is need to maintain these rates by IEC activities and community participation.

show abstract

Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district, Telangana, India

Cited by 6 publications

References 2 publications

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Mass Drug Administration Coverage Evaluation for Elimination of Lymphatic Filariasis in Nagpur District of Maharashtra

Evaluation of coverage, compliance of mass drug administration and assessment of awareness about lymphatic filariasis in Tikamgarh district of Madhya Pradesh: a cross sectional study

Evaluation of coverage of mass drug administration programme conducted in Nalgonda district of Telangana state

Contact Info

Product

Resources

About